Pargluva, a proposed diabetes drug from Bristol-Myers Squibb and Merck & Company, appears to increase the risk of death, heart attack or stroke, according to a study published in a leading medical journal last week.
The study was conducted by the two Cleveland Clinic cardiologists who warned in 2001 about the cardiovascular risks associated with Vioxx, […]
Entries from October 2005
Study Finds Pargluva May Increase Risk of Heart Attack or Stroke
October 27th, 2005 · No Comments
Tags: Pargluva
iPod Nano Lawsuit Filed Against Apple
October 26th, 2005 · 1 Comment
Jason Tomczak, an iPod Nano owner, has filed a lawsuit against Apple Computers, Inc. alleging the company launched the digital music player despite knowing that it was defective.
The lawsuit, filed in the U.S. District Court in San Jose, California, claims that the iPod Nano scratches “excessively during normal usage,” rendering the screen on it unreadable, […]
Tags: Apple
EA Agrees to Pay $15.6 Million to Settle Class Action on Overtime
October 17th, 2005 · No Comments
Electronic Arts has agreed to pay $15.6 million to settle a class action lawsuit brought by computer graphic artists seeking overtime compensation, the company announced on Oct. 5, 2005. The class includes computer graphic artists, including “animators,” “modelers,” “Texture artists,” “lighters,” “background effects artists,” “special effects artists” and “environmental artists,” who worked at EA’s California […]
Tags: Overtime
Paxil May Increase Risk of Birth Defects
October 4th, 2005 · No Comments
Paxil, an antidepressant drug, may increase the risk of birth defects for pregnant women taking it during the first trimester, the Food and Drug Administration warned last week.
The warning comes after Paxil manufacturer GlaxoSmithKline sent the FDA and doctors a letter about preliminary results from a study suggest an increase in the risk of congenital […]
Tags: Paxil
Strattera Linked to Suicidal Thinking in Children
October 4th, 2005 · 1 Comment
Strattera, an attention deficit hyperactivity disorder drug, may increase suicidal thinking in children and adolescents, the Food and Drug Administration warned on Thursday.
“Children and adolescents being treated with Strattera should be closely monitored for clinical worsening, as well as agitation, irritability, suicidal thinking or behaviors, and unusual changes in behavior, especially during the initial few […]
Tags: Strattera

